Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...

Spokane Police and the City Council have agreed after public outcry to scrap the purchase of two portable high-range speakers ...

Families file wrongful death lawsuit against Camp Mystic after six young girls died in Guadalupe River flooding, alleging ...

Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...

Presented detailed efficacy and safety results from the PIK3CA wild-type ("WT") cohort of the Phase 3 VIKTORIA-1 clinical trial at a late breaking oral presentation at the 2025 European Society for Me ...

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

Company continues growth momentum, reduces net loss 90.3% over prior year quarter, and accelerates path to Adjusted EBITDA breakeven ...

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.

Industrial packaging waste—from pallet wrap and strapping to crates and drums—quietly drains profit and inflates carbon ...

Think your home is your safe haven? Unfortunately, that cozy feeling might be masking some serious hazards lurking in plain ...